We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Immunex Files Patent Infringement Complaint Against Sanofi, Regeneron
Immunex Files Patent Infringement Complaint Against Sanofi, Regeneron
In a complaint filed in the District Court of the Central District of California, Immunex asserts Sanofi and Regeneron infringed on the Immunex patent for Dupixent, which the FDA approved in March to treat atopic dermatitis, a form of eczema.